Cluster Advisory Board

Onderzoeker met buisje bloed in lab

As part of a new research funding strategy aimed at maximizing impact, KWF has adopted a more targeted funding approach within thematic ‘tracks’. 

The tracks, identified and developed in close collaboration with the oncological field, are grouped in four clusters: 

To connect with the field and receive continuous feedback, KWF will set up advisory boards for every cluster. These cluster-specific advisory boards will consist of experts from the field: besides researchers,other expertises and perspectives will be included, such as from patients, health care professionals and industry.   

A Cluster Advisory Board will advise KWF and evaluate whether the tracks contribute to KWF's mission goals. Advisory boards can also identify new tracks and advise KWF on the funding of specific opportunistic research initiatives outside our regular and targeted research calls. In order to do so, the advisory boards can be temporarily extended with additional relevant expertise when needed.   

The size of these boards is (ideally) limited, but with a minimum of 5 board members. Potential board members will be asked by KWF and installed for 4 years (this term can be prolonged for 4 years).   

Composition of the Cluster Advisory Boards

Chair:
Prof. dr. Manon van Engeland, Maastricht UMC

Vice chair:
Prof. dr. Peter Devilee, Leiden UMC

Members:
Sandra van Dijk, RIVM
Carin Louis, NFK
Prof. dr. Gerrit Meijer, NKI
Drs. Joris Schuurmans, Ismedrix
Prof. dr. Pieter Tanis, Erasmus MC
Prof. dr. Rozemarijn Vliegenthart, UMC Groningen